ARCHIVES

New Safety Concerns On ESAs Prompt FDA To Consult ODAC Again.

This article is from The Cancer Letter archive.

Vol. 34 No. 01 | January 11, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

13th Congress Advance Program Announcement Now Available

May 1, 1981

Funding Opportunity: DOD Offering 10.5 Million For Lung Cancer Research

May 30, 2014

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Reinventing NCI: Natural Products Screen Closes; NCI Targets Drug Resistance

December 13, 1996

Did ACS Flip-Flop On Stem Cell Research? Society Says No, Patient Coalition Says Yes

September 10, 1999